Benzinga

Benzinga

Benzinga

samedi, août 29

XORTX Therapeutics Inc

XRTXNASDAQ
Trade with Public
Trade with Public
$2.34
-0.10-4.18%
À la clôture: Aug 28, 5:00 PM EST
$2.18
-0.16-6.76%
Après les heures: 4:51 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentComparerRapport sur les stocks

XORTX Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for XORTX Therapeutics (XRTX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$14Upside to Avg. PT+542.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jan 4, 2024Alliance Global PartnersJames MolloyPT RaiseBuy$9→$14

Analyst Ratings News

PRO
Alliance Global Partners Maintains Buy on XORTX Therapeutics, Raises Price Target to $14

Alliance Global Partners analyst James Molloy maintains XORTX Therapeutics (NASDAQ:XRTX) with a Buy and raises the price target from $9 to $14.
Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021

Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:NVEI) was changed from Market Perform to Outperform.
Benzinga Insights

PRO
Alliance Global Partners Initiates Coverage On XORTX Therapeutics with Buy Rating, Announces Price Target of $11

Alliance Global Partners analyst James Molloy initiates coverage on XORTX Therapeutics (NASDAQ:XRTX) with a Buy rating and announces Price Target of $11.
Benzinga Newsdesk

Analysts Comment on Xyratex Acquisition Bids, Shares Continue to Gain

Benzinga

Wells Fargo Comments on Xyratex on In-Line Demand with Storage Subsystem Expectations

Benzinga

UPDATE: Cantor Fitzgerald Reiterates Hold Rating, Lowers PT on Xyratex

Benzinga

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved